2.50
Hdl Handle:
http://hdl.handle.net/10755/164863
Category:
Abstract
Type:
Presentation
Title:
Development of a Breast Cancer Risk Assessment Program
Author(s):
Snyder, Laurel
Author Details:
Laurel Snyder, National Naval Medical Center, Bethesda, Maryland, USA
Abstract:
Advances in the chemoprevention of breast cancer over the last five years have given women at high-risk management options for the first time. Results from the Breast Cancer Prevention Trial (BCPT) clearly demonstrated that tamoxifen, a selective estrogen receptor modulator (SERM), could reduce breast cancer by 50%. The FDA approval of tamoxifen in 1997 for use in prevention challenged providers to identify women who might benefit from tamoxifen, as well as those women in which the risks outweigh the benefits. The Breast Care Center at the National Naval Medical Center is a multidisciplinary facility jointly run by the National Cancer Institute and the Navy. In response to the numerous requests for prevention information after the results of the BCPT were released, a breast cancer education session and risk assessment program was developed. The intention was to provide patients with general information about breast cancer, risk assessment, and prevention. It was anticipated that there would be an increased need within the clinic for healthcare providers to discuss options available to women not only at increased risk for breast cancer, but for those individuals looking for overall breast cancer prevention information. There was a concern that many of the providers would be unable to adequately discuss this information with the patients in both a timely and efficient manner. Since the implementation of the bi-monthly education program in March 1999, the session has effectively provided baseline information on breast cancer, risks, prevention options, clinical trials, and information regarding their personal risk of breast cancer. This has allowed more appropriate triage for the high-risk patients needing further consultation from those patients who just required general information. Patients have provided both verbal and written satisfaction with the information provided in the class and have thus become active participants in their health care. In addition, this baseline information allows for a more focused and time efficient consultation with a provider. This experience suggests that group education may be a viable and acceptable way to bring new advances in breast cancer prevention to large groups of women and their significant others.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2002
Conference Name:
27th Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
Washington, D.C., USA
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titleDevelopment of a Breast Cancer Risk Assessment Programen_GB
dc.contributor.authorSnyder, Laurelen_US
dc.author.detailsLaurel Snyder, National Naval Medical Center, Bethesda, Maryland, USAen_US
dc.identifier.urihttp://hdl.handle.net/10755/164863-
dc.description.abstractAdvances in the chemoprevention of breast cancer over the last five years have given women at high-risk management options for the first time. Results from the Breast Cancer Prevention Trial (BCPT) clearly demonstrated that tamoxifen, a selective estrogen receptor modulator (SERM), could reduce breast cancer by 50%. The FDA approval of tamoxifen in 1997 for use in prevention challenged providers to identify women who might benefit from tamoxifen, as well as those women in which the risks outweigh the benefits. The Breast Care Center at the National Naval Medical Center is a multidisciplinary facility jointly run by the National Cancer Institute and the Navy. In response to the numerous requests for prevention information after the results of the BCPT were released, a breast cancer education session and risk assessment program was developed. The intention was to provide patients with general information about breast cancer, risk assessment, and prevention. It was anticipated that there would be an increased need within the clinic for healthcare providers to discuss options available to women not only at increased risk for breast cancer, but for those individuals looking for overall breast cancer prevention information. There was a concern that many of the providers would be unable to adequately discuss this information with the patients in both a timely and efficient manner. Since the implementation of the bi-monthly education program in March 1999, the session has effectively provided baseline information on breast cancer, risks, prevention options, clinical trials, and information regarding their personal risk of breast cancer. This has allowed more appropriate triage for the high-risk patients needing further consultation from those patients who just required general information. Patients have provided both verbal and written satisfaction with the information provided in the class and have thus become active participants in their health care. In addition, this baseline information allows for a more focused and time efficient consultation with a provider. This experience suggests that group education may be a viable and acceptable way to bring new advances in breast cancer prevention to large groups of women and their significant others.en_GB
dc.date.available2011-10-27T12:08:21Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:08:21Z-
dc.conference.date2002en_US
dc.conference.name27th Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationWashington, D.C., USAen_US
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.